Immunotherapeutic agent

Details Immunotherapeutic agent Immunotherapeutic agent

2005-11-22

2009-08-04

Nazario-Gonzalez, Porfirio (Department: 1621)

Drug, bio-affecting and body treating compositions

Topical body preparation containing solid synthetic organic...

Anti-inflammatory or anti-irritant

C424S078020, C554S227000, C554S223000, C554S224000, C514S547000

Reexamination Certificate

active

07569213

ABSTRACT:
The invention relates to a compound which is an ester of 1,2,3-propanetriol with one or more C11to C24fatty acids, wherein at least one fatty acid has at least one double bond. The compound is useful in the treatment of chronic inflammatory disorders.

REFERENCES:
patent: 3988446 (1976-10-01), Paris et al.
patent: 4178373 (1979-12-01), Foxx et al.
patent: 5709855 (1998-01-01), Bockow et al.
patent: 5807572 (1998-09-01), Kim et al.
patent: 5866703 (1999-02-01), Horrobin et al.
patent: 6479070 (2002-11-01), Cain et al.
patent: 6589520 (2003-07-01), Hoppe et al.
patent: 3314786 (1984-10-01), None
patent: 0 289 204 (1988-11-01), None
patent: 0 311 091 (1989-04-01), None
patent: 0 491 076 (1992-06-01), None
patent: 2 300 807 (1996-11-01), None
patent: 63-088123 (1988-04-01), None
patent: 02129113 (1990-05-01), None
patent: 92/01450 (1992-02-01), None
patent: 93/00326 (1993-01-01), None
patent: 93/21912 (1993-11-01), None
patent: 98/56371 (1998-12-01), None
patent: 99/45916 (1999-09-01), None
patent: 2004/000333 (2003-12-01), None
Barnes, P., New treatments for chronic obstructive plumanory disease, 2003, Ann 1st Super Sanita, vol. 39, No. 4, pp. 573-582.
Knothe, G. et al, Evaluation of C-NMR signals of the unsaturated carbons of triacylglycerols, 1995, Chemistry and Physics of Lipids, vol. 77, pp. 187-191.
Lassmann, H., Recent neuropathological finds in MS-implication sfor diagnosis and therapy, Sep. 2004, Journal of Neurology, vol. 251, supp. 4, pp. 1432-1459.

Affiliated with

Also associated with

Rating

Immunotherapeutic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapeutic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4071067